D.M. Lambert

3.5k total citations · 1 hit paper
23 papers, 2.9k citations indexed

About

D.M. Lambert is a scholar working on Infectious Diseases, Epidemiology and Virology. According to data from OpenAlex, D.M. Lambert has authored 23 papers receiving a total of 2.9k indexed citations (citations by other indexed papers that have themselves been cited), including 14 papers in Infectious Diseases, 12 papers in Epidemiology and 7 papers in Virology. Recurrent topics in D.M. Lambert's work include HIV Research and Treatment (7 papers), HIV/AIDS drug development and treatment (7 papers) and Respiratory viral infections research (6 papers). D.M. Lambert is often cited by papers focused on HIV Research and Treatment (7 papers), HIV/AIDS drug development and treatment (7 papers) and Respiratory viral infections research (6 papers). D.M. Lambert collaborates with scholars based in United States, Slovakia and Germany. D.M. Lambert's co-authors include Patrice D. Cani, Sam Possemiers, Yves Guiot, Audrey M. Neyrinck, Damien Naslain, Giulio G. Muccioli, Nathalie M. Delzenne, Tom Van de Wiele, Lucie Geurts and Amandine Everard and has published in prestigious journals such as Proceedings of the National Academy of Sciences, Journal of Virology and Gut.

In The Last Decade

D.M. Lambert

22 papers receiving 2.8k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Changes in gut microbiota control inflammation in obese mice through a mechanism involving GLP-2-driven improvement of gut permeability

2009 2.0k citations Patrice D. Cani, Sam Possemiers et al. Gut profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
D.M. Lambert United States	13	1.5k	1.0k	743	602	427	23	2.9k
Michael S. Rolph Australia	27	2.5k 1.7×	1.4k 1.4×	855 1.2×	839 1.4×	204 0.5×	43	5.9k
Nina Rautonen Finland	35	1.9k 1.3×	930 0.9×	542 0.7×	353 0.6×	71 0.2×	61	3.9k
Aldo Manzin Italy	35	1.1k 0.8×	442 0.4×	1.6k 2.2×	762 1.3×	424 1.0×	122	3.8k
Jan Kranich Germany	20	2.5k 1.7×	922 0.9×	355 0.5×	522 0.9×	115 0.3×	27	4.1k
Richard L. Kitchens United States	29	972 0.7×	290 0.3×	652 0.9×	194 0.3×	107 0.3×	43	3.4k
Isabelle Wolowczuk France	29	868 0.6×	697 0.7×	752 1.0×	273 0.5×	39 0.1×	66	3.2k
Bikash Sahay United States	21	1.5k 1.0×	707 0.7×	231 0.3×	495 0.8×	67 0.2×	51	2.5k
Thea Magrone Italy	26	631 0.4×	345 0.3×	366 0.5×	284 0.5×	74 0.2×	96	2.6k
Judith Hellman United States	32	1.1k 0.7×	245 0.2×	1.1k 1.4×	416 0.7×	193 0.5×	78	4.0k
Lhousseine Touqui France	39	1.7k 1.1×	376 0.4×	486 0.7×	333 0.6×	42 0.1×	110	4.3k

Countries citing papers authored by D.M. Lambert

Since Specialization

Citations

This map shows the geographic impact of D.M. Lambert's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by D.M. Lambert with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites D.M. Lambert more than expected).

Fields of papers citing papers by D.M. Lambert

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by D.M. Lambert. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by D.M. Lambert. The network helps show where D.M. Lambert may publish in the future.

Co-authorship network of co-authors of D.M. Lambert

This figure shows the co-authorship network connecting the top 25 collaborators of D.M. Lambert. A scholar is included among the top collaborators of D.M. Lambert based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with D.M. Lambert. D.M. Lambert is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Cani, Patrice D., Sam Possemiers, Tom Van de Wiele, et al.. (2009). Changes in gut microbiota control inflammation in obese mice through a mechanism involving GLP-2-driven improvement of gut permeability. Gut. 58(8). 1091–1103. 1999 indexed citations breakdown →

Lambert, D.M., et al.. (2002). C-Terminal gp40 Peptide Analogs Inhibit Feline Immunodeficiency Virus: Cell Fusion and Virus Spread. Journal of Virology. 76(18). 9079–9086. 23 indexed citations

Barney, Shawn, et al.. (1998). Pentafuside , a novel inhibitor of HIV-1 fusion and infection, is synergistic when used in combination with reverse transcriptase and protease inhibitors in vitro. Antiviral Research. 37(3). 54. 2 indexed citations

Lambert, D.M., Shawn Barney, Anick Lambert, et al.. (1996). Peptides from conserved regions of paramyxovirus fusion (F) proteins are potent inhibitors of viral fusion.. Proceedings of the National Academy of Sciences. 93(5). 2186–2191. 288 indexed citations

Pendrak, Israil, Shawn Barney, Robert J. Wittrock, D.M. Lambert, & William D. Kingsbury. (1994). ChemInform Abstract: Synthesis and Anti‐HSV Activity of A‐Ring‐Deleted Mappicine Ketone Analogue.. ChemInform. 25(44). 2 indexed citations

Lambert, D.M., H F Bartus, Jeffry J. Leary, et al.. (1993). Synergistic drug interactions of an HIV-1 protease inhibitor with AZT in different in vitro models of HIV-1 infection. Antiviral Research. 21(4). 327–342. 16 indexed citations

Collet, E., et al.. (1993). Abcès cutanés récidivants: rôle pathogène de Mycobacterium terrae?. La Revue de Médecine Interne. 14(10). 1119–1120. 1 indexed citations

Black, Paul L., Mark G. Lewis, Michael A. Ussery, et al.. (1993). Antiretroviral activities of protease inhibitors against murine leukemia virus and simian immunodeficiency virus in tissue culture. Antimicrobial Agents and Chemotherapy. 37(1). 71–77. 12 indexed citations

Ahmed, Khalil, et al.. (1993). Cloning of cDNAs encoding the alpha and beta subunits of rat casein kinase 2 (CK-2): investigation of molecular regulation of CK-2 by androgens in rat ventral prostate.. PubMed. 39(5). 451–62. 5 indexed citations

10.

Lambert, D.M., Stephen R. Petteway, T K Hart, et al.. (1992). Human immunodeficiency virus type 1 protease inhibitors irreversibly block infectivity of purified virions from chronically infected cells. Antimicrobial Agents and Chemotherapy. 36(5). 982–988. 54 indexed citations

11.

Hart, T K, Richard Kirsh, Harma Ellens, et al.. (1991). Binding of soluble CD4 proteins to human immunodeficiency virus type 1 and infected cells induces release of envelope glycoprotein gp120.. Proceedings of the National Academy of Sciences. 88(6). 2189–2193. 185 indexed citations

12.

Giroud, M, P. Oriol, D.M. Lambert, et al.. (1990). [Erythema multiforme induced by the combination of phenytoin and cerebral irradiation].. PubMed. 45(1). 23–5. 4 indexed citations

13.

Dalac, S., et al.. (1990). [Sweet's syndrome and Yersinia enterocolitica infection].. PubMed. 117(11). 858–60. 14 indexed citations

14.

Lambert, D.M., et al.. (1988). Kinetics of Synthesis and Phosphorylation of Respiratory Syncytial Virus Polypeptides. Journal of General Virology. 69(2). 313–323. 33 indexed citations

15.

Wechsler, Steven L., D.M. Lambert, Mark S. Galinski, et al.. (1987). Immediate Persistent Infection by Human Parainfluenza Virus 3: Unique Fusion Properties of the Persistently Infected Cells. Journal of General Virology. 68(6). 1737–1748. 12 indexed citations

16.

Wechsler, Steven L., D.M. Lambert, Mark S. Galinski, & Marcel W. Pons. (1985). Intracellular synthesis of human parainfluenza type 3 virus-specified polypeptides. Journal of Virology. 54(3). 661–664. 37 indexed citations

17.

Pons, Marcel W., et al.. (1983). Improvement of respiratory syncytial virus replication in actively growing HEp-2 cells. Journal of Virological Methods. 7(4). 217–221. 4 indexed citations

18.

Lambert, D.M. & Marcel W. Pons. (1983). Respiratory syncytial virus glycoproteins. Virology. 130(1). 204–214. 44 indexed citations

19.

Lambert, D.M., et al.. (1980). Nucleic acids of respiratory syncytial virus. Journal of Virology. 36(3). 837–846. 20 indexed citations

20.

Brünner, Helmut, et al.. (1976). Response of guinea pigs and hamsters to experimental infection withMycoplasma pneumoniae. Infection. 4(S1). S13–S16.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact